Physician

Ning Sarah Yang

According to 2025 Medicare claims, Ning Yang (NPI: 1275809675) practices neurology in the Fort Collins-Loveland, CO market, with the plurality of this provider's patient population coming from Larimer, CO. This provider's primary affiliated billing organization is ADVANCED NEUROLOGY OF COLORADO, LLC (NPI: 1972556991; TIN: 680562419) and primary practice location at 80528-3401. Yang is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Yang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 277 traditional Medicare patients, billed 17,763 HCPCS/CPT codes, and received $153,849 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,266 prescription claims across 241 beneficiaries totaling $4,461,221 in drug costs, led by Vyvgart Hytrulo (Efgartigimod-Hyaluronidas-Qvfc). Open Payments data shows 226 records totaling $27,400. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $20,043 and ending at $153,849. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $185,157 to $4,461,221. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	115	997	$20,043
2018	270	5,186	$61,371
2019	234	2,301	$45,367
2020	167	1,528	$36,755
2021	194	2,964	$53,971
2022	197	2,932	$49,019
2023	174	3,867	$58,866
2024	277	17,763	$153,849

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	183	$185,157
2016	15	145	$204,084
2017	93	266	$93,017
2018	233	1,393	$667,800
2019	244	1,360	$1,094,298
2020	169	697	$624,636
2021	176	817	$588,260
2022	177	667	$549,466
2023	162	654	$1,980,653
2024	241	1,266	$4,461,221

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	70	82	$136
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	65	65	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	128	175	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	54	63	$68
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	182	290	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyvgart Hytrulo	Efgartigimod-Hyaluronidas-Qvfc	15	498	$860,805
Zilbrysq	Zilucoplan Sodium	18	504	$763,045
Gammaked	Immune Globul G/Gly/Iga Avg 46	45	1,253	$723,340
Ultomiris	Ravulizumab-Cwvz	15	522	$670,460
Gammaplex	Immun Glob G(Igg)/Gly/Iga 0-50	15	420	$327,021

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	226	$27,400	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ning Sarah Yang?

Tedicare shows public-source Medicare data for Ning Sarah Yang (NPI 1275809675), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ning Sarah Yang have ACO affiliation data?

Ning Sarah Yang is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Ning Sarah Yang?

Ning Sarah Yang is linked to ADVANCED NEUROLOGY OF COLORADO, LLC (billing NPI 1972556991) in the available physician profile data.

Does Ning Sarah Yang have Open Payments data?

Ning Sarah Yang has 226 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.